Stephens »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Stephens

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Stephens from 13F filings

Historical chart of Stephens investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Stephens consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Stephens

Quarter filed Position value Share count Share price at filing
2026-06-30 $39k 33k 1.19

More positions owned by Stephens

Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Val Etf (IWD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Rus Mdcp Val Etf (IWS)

View all positions for Stephens

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Linden Advisors
Ubs Global Asset Management Americas
Readystate Asset Management
Lazard Asset Management
Calamos Advisors
MacKay Shields
DeepCurrents Investment Group
Context Capital Management
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Oaktree Capital Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1